Instrument Inactif

Cours Kun Run Biotechnology, Inc.

Actions

Durée

Période

Style

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	17/06/10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	22/04/10
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	30/03/10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	13/11/09
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	01/04/09

Secteur

	Varia. 1 janv.	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20,40 %	44,1 Md
OTSUKA HOLDINGS CO., LTD.	+17,11 %	21,97 Md
CIPLA LIMITED	+8,10 %	13,27 Md
SANDOZ GROUP AG	+6,06 %	13,22 Md
ZYDUS LIFESCIENCES LIMITED	+35,95 %	11,36 Md
ONO PHARMACEUTICAL CO., LTD.	-8,53 %	7,07 Md
THE MEDICINES COMPANY	-0,05 %	6,79 Md
STADA ARZNEIMITTEL	-8,87 %	5,73 Md
ASPEN PHARMACARE HOLDINGS LIMITED	+10,09 %	5,23 Md